Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.86 is 11% below its 5-year average of 3.20, near the low end of its 5-year range (2.38–4.78).
As of the fiscal period ended Tuesday, June 30, 2026. 4.67% above its 12-month average of 2.73.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.86.
CURRENT RATIO
2.86
CURRENT RATIO AVG TTM
2.73
CURRENT RATIO AVG 3Y
2.93
CURRENT RATIO AVG 5Y
3.20
CURRENT RATIO AVG 10Y
7.51
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.67%
CURRENT VS 3Y AVG
-2.49%
CURRENT VS 5Y AVG
-10.54%
CURRENT VS 10Y AVG
-61.96%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.72
median of 865 covered companies
CURRENT VS SECTOR MEDIAN
-23.16%
vs the sector median at left
Market Cap
$397.20M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$381.78M
Current Ratio
5.23
TTM Avg
9.53
3Y Avg
5.00
5Y Avg
3.80
Market Cap
$376.75M
Current Ratio
5.88
TTM Avg
5.65
3Y Avg
4.80
5Y Avg
5.41
Market Cap
$404.16M
Current Ratio
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$375.71M
Current Ratio
9.06
TTM Avg
8.18
3Y Avg
5.96
5Y Avg
5.74
Market Cap
$374.16M
Current Ratio
3.04
TTM Avg
3.23
3Y Avg
2.34
5Y Avg
4.58
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | $390.36M | 2.86 | 2.73 | 2.93 | 3.20 |
| Orthofix Medical Inc. (OFIX)vs › | $385.62M | 2.84 | 2.51 | 2.66 | 2.63 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $397.20M | 16.52 | 13.61 | 8.86 | 8.86 |
| YD Bio Limited Ordinary Shares (YDES)vs › | $381.78M | 5.23 | 9.53 | 5.00 | 3.80 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $376.75M | 5.88 | 5.65 | 4.80 | 5.41 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.16M | 8.13 | 16.34 | 21.67 | 17.16 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $375.71M | 9.06 | 8.18 | 5.96 | 5.74 |
| Canopy Growth Corporation (CGC)vs › | $374.16M | 3.04 | 3.23 | 2.34 | 4.58 |
| Carlsmed, Inc. (CARL)vs › | $406.69M | 8.84 | 7.23 | 5.35 | 5.35 |
| Neurogene Inc. (NGNE)vs › | $406.75M | 10.64 | 18.70 | 14.71 | 15.05 |
Current Ratio
2.86
Quick Ratio
2.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.86 |
| 2026-03-31 | 2.62 |
| 2025-12-31 | 2.38 |
| 2025-09-30 | 2.66 |
| 2025-06-30 | 3.13 |
| 2025-03-31 | 2.93 |
| 2024-12-31 | 2.69 |
| 2024-09-30 | 3.05 |
| 2024-06-30 | 3.53 |
| 2024-03-31 | 3.59 |
| 2023-12-31 | 2.57 |
| 2023-09-30 | 2.87 |
| 2023-06-30 | 3.21 |
| 2023-03-31 | 3.46 |
| 2022-12-31 | 3.19 |
| 2022-09-30 | 3.53 |
| 2022-06-30 | 4.06 |
| 2022-03-31 | 3.73 |
| 2021-12-31 | 3.98 |
| 2021-09-30 | 3.84 |
| 2021-06-30 | 4.78 |
| 2021-03-31 | 5.94 |
| 2020-12-31 | 6.52 |
| 2020-09-30 | 6.08 |
| 2020-06-30 | 8.19 |
| 2020-03-31 | 10.64 |
| 2019-12-31 | 10.25 |
| 2019-09-30 | 11.49 |
| 2019-06-30 | 14.58 |
| 2019-03-31 | 14.21 |
| 2018-12-31 | 15.24 |
| 2018-09-30 | 20.21 |
| 2018-06-30 | 17.40 |
| 2018-03-31 | 17.66 |
| 2017-12-31 | 11.64 |
| 2017-09-30 | 12.85 |
| 2017-06-30 | 14.47 |
| 2017-03-31 | 14.94 |
| 2016-12-31 | 9.66 |
| 2016-09-30 | 6.72 |
| 2016-06-30 | 10.70 |
| 2016-03-31 | 18.26 |
| 2015-12-31 | 27.23 |
| 2015-09-30 | 40.60 |
| 2015-06-30 | 14.42 |
| 2015-03-31 | 3.76 |
| 2014-12-31 | 0.33 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
